Arthur T. Sands
2012 - Lexicon Pharmaceuticals
In 2012, Arthur T. Sands earned a total compensation of $1.9M as Former President, Chief Executive Officer and Director at Lexicon Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Bonus | $215,000 |
|---|---|
| Option Awards | $810,152 |
| Salary | $580,000 |
| Stock Awards | $266,400 |
| Other | $6,970 |
| Total | $1,878,522 |
Sands received $810.2K in option awards, accounting for 43% of the total pay in 2012.
Sands also received $215K in bonus, $580K in salary, $266.4K in stock awards and $7K in other compensation.
Rankings
In 2012, Arthur T. Sands' compensation ranked 3,791st out of 11,487 executives tracked by ExecPay. In other words, Sands earned more than 67.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,791 out of 11,487 | 67th |
Division Manufacturing | 1,318 out of 4,253 | 69th |
Major group Chemicals And Allied Products | 293 out of 1,198 | 76th |
Industry group Drugs | 172 out of 920 | 81st |
Industry Pharmaceutical Preparations | 133 out of 700 | 81st |
Source: SEC filing on March 13, 2015.
Sands' colleagues
We found four more compensation records of executives who worked with Arthur T. Sands at Lexicon Pharmaceuticals in 2012.
2012
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2012
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
2012
Alan Main
Lexicon Pharmaceuticals
Executive Vice President, CMC and Supply Operations
2012
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021